🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This is a Phase 1, open-label, multicenter study evaluating the safety, pha...
Status
Completed
Location
Ucsd /Id# 67350
Start Date
2012-05-21
Trial ID
NCT01594229
Treatments Being Tested
Non-Hodgkin CD20 + Indolent Lymphoma (iNHL) and Chronic Lymphatic Leukemia ...
Status
Unknown
Location
ASST - Papa Giovanni XXIII
Start Date
2018-12-17
Trial ID
NCT03823365
Treatments Being Tested
This Phase I/II study is designed to first identify doses of MLN9708 and be...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2015-10-09
Trial ID
NCT02477215
Treatments Being Tested
Gene transfer is a process in which the DNA (genetic material) of certain c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02194374
Treatments Being Tested
The purpose of this study is assess safety, safest dose, and effectiveness ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-10-26
Trial ID
NCT05451771
This is an open label phase I/II trial to determine the safety and the biol...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2010-07
Trial ID
NCT01177683
Treatments Being Tested
The purpose of this study is to determine if it is possible to give CPI-613...
Status
Terminated
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2020-09-16
Trial ID
NCT04217317
Treatments Being Tested
The goal of this study is to characterize the safety, maximum tolerated dos...
Status
Completed
Location
The Colorado Blood Cancer Institute
Start Date
2013-05
Trial ID
NCT01871675
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
Medizinische Universitaetsklinik I at the University of Cologne
Start Date
2003-11
Trial ID
NCT00634881
Treatments Being Tested